Certara Inc (CERT) Stock Price, Quote & News

Company Profile

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharm...

Industry: Health Information Services

Sector: Healthcare

Phone: 415 237 8272

Website: www.certara.com

Address:

4 Radnor Corporate Center, Suite 350, Radnor, United States

BioGem Aug. 9 at 9:57 PM

$CERT This may be shortable soon. Extremely overvalued with critical negatives: -Missed both top and bottom lines. -No growth whatsoever now nor per their tepid and flat guidance. -Continued bottom line losses. -Negative free cash flow. -Huge and expensive debt. -Most importantly: ruthless competition from dozens of similar companies, or from AI models (Claude) that allow bio-simulation to be produced locally by each biotech company itself without needing CERT's services and programs. -Huge short interest = consensus of poor stock performance. -No prestigious biotech fund is invested.

1 · Reply

IDrawLiness Aug. 8 at 11:17 PM

$CERT Rejected several times at the 50EMA but holy cow look at that volume. Buyers closed out a great week. Long.

0 · Reply

Gundam2168 Aug. 6 at 9:34 PM

$BULL $CERT What Caused This Spike?This specific type of late-day trading behavior usually points to two common institutional mechanics rather than retail hype:Market-on-Close (MOC) Institutional Orders: Large mutual funds and index trackers accumulate shares throughout the day but mandate that their final executions take place exactly at the official closing price to minimize tracking error.Short-Covering Into Strength: With short interest sitting exceptionally high on the public float, short sellers who wanted to de-risk ahead of the Friday session likely bought blocks at the close to avoid getting trapped over the weekend.The heavy buying allowed the stock to close strong at $8.13, establishing a solid immediate support shelf after its post-earnings volatility earlier in the week.

0 · Reply

Gundam2168 Aug. 6 at 9:33 PM

$BULL $CERT Breaking Down the Last 30 Minutes of TradingThe data highlights a clear shift from quiet, baseline algorithmic trading to institutional block orders during the market close:12:30 PM – 12:50 PM (PDT): Trading was extremely quiet. Volume hovered between a tiny 7,700 and 32,500 shares per 5-minute interval, with the stock pinned flat around $8.06 to $8.07.12:55 PM (PDT): Momentum began to turn as a wave of buying absorbed 166,136 shares, pushing the stock price up from $8.09 to $8.13.1:00 PM Closing Candle (PDT): A massive block order hit the tape, executing 2,620,034 shares right at the closing bell. This single 5-minute window accounted for a significant portion of the entire day's market liquidity.

0 · Reply

Gundam2168 Aug. 6 at 9:32 PM

$BULL $CERT Here's what I found for CERT: there was a massive surge of heavy buying in the final 10 minutes of the trading session today.Intraday transaction logs show that trading volume spiked dramatically right before the closing bell, driving a micro-breakout in Certara's stock price.

0 · Reply

Gundam2168 Aug. 6 at 9:05 PM

$BULL $CERT Take a look at CERT. A breakout might be around the corner if it go pass $8.20 with 5 million volume traded on that day.

0 · Reply

EarningsInsider Aug. 4 at 1:46 PM

https://www.marketbeat.com/earnings/reports/2026-8-4-certara-inc-stock/ $CERT Certara Earnings Transcript

0 · Reply

OpenOutcrier Aug. 4 at 12:42 PM

$CERT (-24.1% pre) Certara Non-GAAP EPS of $0.08 misses by $0.01, revenue of $93.3M misses by $4.78M https://ooc.bz/l/109808

0 · Reply

StocktwitsEarnings Aug. 4 at 11:23 AM

$CERT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.36 down -3500.00% YoY • Reported revenue of $93.27M down -10.81% YoY

0 · Reply

basebreakouts Jul. 28 at 7:10 PM

$CERT i entered this today. someone who knows about it can you give me a rundown

0 · Reply

Certara price target raised to $7 from $6 at Baird

2026-08-05T14:14:45.000Z - 9 days ago

Certara price target lowered to $9 from $10 at Morgan Stanley

2026-08-05T09:10:45.000Z - 9 days ago

Certara price target raised to $7.50 from $6.50 at Barclays

Aug 4, 2026, 8:30 AM EDT - 10 days ago

Certara Earnings Call Transcript: Q2 2026

Aug 4, 2026, 8:30 AM EDT - 10 days ago

Certara Earnings release: Q2 2026

Aug 4, 2026, 8:30 AM EDT - 10 days ago

Certara Quarterly report: Q2 2026

Aug 4, 2026, 8:30 AM EDT - 10 days ago

Certara Slides: Q2 2026

2026-08-04T12:11:14.000Z - 10 days ago

Certara backs FY26 adjusted EPS view 31c-36c, consensus 38c

2026-08-04T12:05:31.000Z - 10 days ago

Certara reports Q2 adjusted EPS 8c, consensus 9c

Aug 4, 2026, 7:00 AM EDT - 10 days ago

Certara Reports Second Quarter 2026 Financial Results

Jul 15, 2026, 4:15 PM EDT - 4 weeks ago

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

2026-07-07T12:26:18.000Z - 5 weeks ago

Certara partners with Nvidia to advance open integrated AI platform

NVDA

Jul 7, 2026, 8:00 AM EDT - 5 weeks ago

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

Jun 18, 2026, 7:15 PM EDT - 2 months ago

Certara, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

2026-06-17T20:36:22.000Z - 2 months ago

Certara announces CFO transition; affirms FY26 guidance

Jun 17, 2026, 4:30 PM EDT - 2 months ago

Certara Announces CFO Transition

2026-06-16T14:30:11.000Z - 2 months ago

Leerink says Certara peer acquisition supports higher multiple

SLP

Jun 3, 2026, 1:20 PM EDT - 2 months ago

Certara Transcript: Jefferies Global Healthcare Conference 2026

May 19, 2026, 9:30 AM EDT - 3 months ago

Certara Transcript: RBC Capital Markets Global Healthcare Conference 2026

May 18, 2026, 4:15 PM EDT - 3 months ago

Certara to Participate in Upcoming Investor Conferences

May 14, 2026, 9:00 AM EDT - 3 months ago

Certara Transcript: AGM 2026

2026-05-12T16:12:37.000Z - 3 months ago

Certara price target lowered to $6 from $7 at BMO Capital

2026-05-12T13:32:57.000Z - 3 months ago

Certara price target lowered to $8 from $10 at Craig-Hallum

2026-05-12T12:01:07.000Z - 3 months ago

Certara price target lowered to $9 from $10 at Stephens

2026-05-12T11:33:46.000Z - 3 months ago

Certara price target lowered to $6 from $7 at Baird

2026-05-12T11:25:28.000Z - 3 months ago

Certara price target lowered to $10 from $11 at Morgan Stanley

2026-05-11T20:06:48.000Z - 3 months ago

Certara trading halted, volatility trading pause

2026-05-11T19:51:41.000Z - 3 months ago

Certara trading resumes

2026-05-11T17:52:37.000Z - 3 months ago

Certara price target lowered to $6.50 from $8 at Barclays

May 11, 2026, 8:30 AM EDT - 3 months ago

Certara Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Certara Slides: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Certara Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Certara Quarterly report: Q1 2026

2026-05-11T11:35:34.000Z - 3 months ago

Certara reports Q1 adjusted EPS 9c, consensus 11c

May 11, 2026, 6:25 AM EDT - 3 months ago

Certara Reports First Quarter 2026 Financial Results

May 7, 2026, 8:00 AM EDT - 3 months ago

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

Apr 22, 2026, 7:00 AM EDT - 4 months ago

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

Apr 22, 2026, 7:00 AM EDT - 4 months ago

Veristat to Acquire Certara's Regulatory and Medical Writing Business

Apr 9, 2026, 4:15 PM EDT - 4 months ago

Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

Apr 3, 2026, 8:00 AM EDT - 4 months ago

Certara Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 4 months ago

Certara Proxy statement: Proxy filing

Mar 10, 2026, 1:00 PM EDT - 5 months ago

Certara Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 9, 2026, 8:00 AM EDT - 5 months ago

Certara Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 3:10 PM EST - 5 months ago

Certara Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 8:00 AM EST - 5 months ago

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Feb 26, 2026, 8:30 AM EST - 6 months ago

Certara Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Certara Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Certara Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Certara Slides: Q4 2025

Feb 26, 2026, 6:00 AM EST - 6 months ago

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

Jan 29, 2026, 8:30 AM EST - 7 months ago

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025

Dec 31, 2025, 10:57 AM EST - 8 months ago

Tax-related selling could set up these 11 stocks for big gains early in 2026

CNH CNS COTY FRSH GOGO JJSF KNTK

Dec 11, 2025, 6:00 AM EST - 8 months ago

Certara Appoints Jon Resnick as Chief Executive Officer

Nov 18, 2025, 2:00 PM EST - 9 months ago

Certara Transcript: Stephens Annual Investment Conference

Nov 18, 2025, 5:30 AM EST - 9 months ago

Certara Transcript: Jefferies London Healthcare Conference 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Certara Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Certara Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Certara Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Certara Slides: Q3 2025

Nov 6, 2025, 4:15 PM EST - 10 months ago

Certara Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 8:00 AM EST - 10 months ago

Certara Automates Scientific Workflows with Phoenix® Cloud

Oct 30, 2025, 4:15 PM EDT - 10 months ago

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Oct 20, 2025, 8:00 AM EDT - 10 months ago

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Oct 10, 2025, 8:00 AM EDT - 11 months ago

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Sep 23, 2025, 6:34 PM EDT - 11 months ago

Final Trade: CERT, GDX, IWM, MPC

GDX IWM MPC

Sep 10, 2025, 12:20 PM EDT - 1 year ago

Certara Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 10:15 AM EDT - 1 year ago

Certara Transcript: Baird Global Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Certara Earnings Call Transcript: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Certara Quarterly report: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Certara Earnings release: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Certara Slides: Q2 2025

Aug 6, 2025, 4:15 PM EDT - 1 year ago

Certara Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 2:00 AM EDT - 1 year ago

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Jul 31, 2025, 4:15 PM EDT - 1 year ago

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Jul 9, 2025, 4:15 PM EDT - 1 year ago

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Jul 8, 2025, 8:00 AM EDT - 1 year ago

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Jun 4, 2025, 1:40 PM EDT - 1 year ago

Certara Transcript: 45th Annual William Blair Growth Stock Conference

Jun 4, 2025, 1:40 PM EDT - 1 year ago

Certara Slides: 45th Annual William Blair Growth Stock Conference

May 13, 2025, 6:40 PM EDT - 1 year ago

Certara Transcript: Bank of America 2025 Healthcare Conference

May 5, 2025, 5:00 PM EDT - 1 year ago

Certara Earnings Call Transcript: Q1 2025

May 5, 2025, 5:00 PM EDT - 1 year ago

Certara Quarterly report: Q1 2025

May 5, 2025, 5:00 PM EDT - 1 year ago

Certara Earnings release: Q1 2025

May 5, 2025, 5:00 PM EDT - 1 year ago

Certara Slides: Q1 2025

May 5, 2025, 4:15 PM EDT - 1 year ago

Certara Reports First Quarter 2025 Financial Results

Apr 14, 2025, 8:15 AM EDT - 1 year ago

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Certara Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Certara Proxy statement: Proxy Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Mar 12, 2025, 11:30 AM EDT - 1 year ago

Certara Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 5, 2025, 4:15 PM EST - 1 year ago

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Feb 26, 2025, 5:00 PM EST - 1 year ago

Certara Earnings Call Transcript: Q4 2024

Feb 26, 2025, 5:00 PM EST - 1 year ago

Certara Annual report: Q4 2024

Feb 26, 2025, 5:00 PM EST - 1 year ago

Certara Earnings release: Q4 2024

Feb 26, 2025, 5:00 PM EST - 1 year ago

Certara Slides: Q4 2024

Feb 26, 2025, 4:15 PM EST - 1 year ago

Certara Reports Fourth Quarter 2024 Financial Results

Jan 29, 2025, 4:15 PM EST - 1 year ago

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Jan 15, 2025, 8:15 PM EST - 1 year ago

Certara Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 8:15 PM EST - 1 year ago

Certara Slides: FY 2025

Jan 15, 2025, 7:55 AM EST - 1 year ago

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Jan 10, 2025, 7:14 PM EST - 1 year ago

Final Trade: CERT, XLE, DAL, OKTA

OKTA XLE DAL

Jan 2, 2025, 4:15 PM EST - 1 year ago

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 2, 2024, 4:15 PM EST - 1 year ago

Certara Showcases 2024 Research Wins With Over 100 Papers Published

Nov 21, 2024, 11:00 AM EST - 1 year ago

Certara Transcript: Stephens 26th Annual Investment Conference | NASH2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Certara Earnings Call Transcript: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Certara Quarterly report: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Certara Earnings release: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Certara Slides: Q3 2024

Nov 6, 2024, 4:15 PM EST - 1 year ago

Certara Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 4:15 PM EDT - 1 year ago

Certara to Participate in the Stephens Annual Investment Conference

Oct 16, 2024, 4:15 PM EDT - 1 year ago

Certara Appoints John Reynders as New Independent Board Member

Oct 9, 2024, 4:15 PM EDT - 2 years ago

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

Oct 2, 2024, 4:15 PM EDT - 2 years ago

Certara Completes Acquisition of Chemaxon

Sep 27, 2024, 6:37 PM EDT - 2 years ago

Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon

KNX LULU NEE

BioGem Aug. 9 at 9:57 PM

1 · Reply

IDrawLiness Aug. 8 at 11:17 PM

$CERT Rejected several times at the 50EMA but holy cow look at that volume. Buyers closed out a great week. Long.

0 · Reply

Gundam2168 Aug. 6 at 9:34 PM

0 · Reply

Gundam2168 Aug. 6 at 9:33 PM

0 · Reply

Gundam2168 Aug. 6 at 9:32 PM

0 · Reply

Gundam2168 Aug. 6 at 9:05 PM

$BULL $CERT Take a look at CERT. A breakout might be around the corner if it go pass $8.20 with 5 million volume traded on that day.

0 · Reply

EarningsInsider Aug. 4 at 1:46 PM

https://www.marketbeat.com/earnings/reports/2026-8-4-certara-inc-stock/ $CERT Certara Earnings Transcript

0 · Reply

OpenOutcrier Aug. 4 at 12:42 PM

$CERT (-24.1% pre) Certara Non-GAAP EPS of $0.08 misses by $0.01, revenue of $93.3M misses by $4.78M https://ooc.bz/l/109808

0 · Reply

StocktwitsEarnings Aug. 4 at 11:23 AM

$CERT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.36 down -3500.00% YoY • Reported revenue of $93.27M down -10.81% YoY

0 · Reply

basebreakouts Jul. 28 at 7:10 PM

$CERT i entered this today. someone who knows about it can you give me a rundown

0 · Reply

RockBottomCapital Jul. 28 at 3:20 PM

$CERT

0 · Reply

RockBottomCapital Jul. 28 at 3:15 PM

$CERT

0 · Reply

IDrawLiness Jul. 26 at 11:27 PM

$CERT $ILMN 🎯

0 · Reply

Shortsqueezegenuis69 Jul. 24 at 3:06 PM

$CERT Coming in at #3 on my short squeeze list. This is the only actionable short squeeze investment, catalyst is FTD closeout on aug 3, earnings the 4th. With nvidia partnership and positive forward guidance coming on earnings. Bought calls at 7.50, aug 21st exp at $7 flat yesterday

0 · Reply

RockBottomCapital Jul. 20 at 3:12 PM

$CERT

0 · Reply

RockBottomCapital Jul. 17 at 1:39 PM

$CERT

0 · Reply

RockBottomCapital Jul. 15 at 2:11 PM

$CERT

0 · Reply